By Andrew M. Seaman NEW YORK (Reuters Health) - Despite a strong warning from U.S. regulators in 2007, for-profit dialysis centers still gave their kidney failure patients more of a certain anemia drug than non-profit centers in 2008, says a new study. The researchers write in JAMA Internal Medicine that their finding suggests for-profit dialysis centers may have been motivated to give more of the drug for financial gain in spite of the warning. For example, the more of the drug the centers used, the more they'd get paid. ... Original Source
No comments:
Post a Comment